Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L D Altstiel

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Alzheimer Disease and Associated Disorders|June 19, 2002
Barriers to Alzheimer disease drug discovery and development in the biotechnology industryL D Altstiel
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1991
Cytokines in Alzheimer's diseaseL D Altstiel, K Sperber
Journal of Virology|July 1, 1981
Structural changes in BHK cell plasma membrane caused by the binding of vesicular stomatitis virusL D Altstiel, F R Landsberger
Dementia (Basel, Switzerland)|January 1, 1995
Elevated alpha 1-antichymotrypsin serum levels in a subset of nondemented first-degree relatives of Alzheimer's disease patientsL D Altstiel, B Lawlor, R Mohs, et al.
The American Journal of Psychiatry|May 20, 1998
Association of elevated alpha 1-antichymotrypsin with cognitive impairment in a prospective study of the very oldS M Gabriel, D B Marin, P S Aisen, et al.
Genetic Epidemiology|January 1, 1996
Apolipoprotein E-epsilon 4 allele and familial risk in Alzheimer's diseaseG Li, J M Silverman, L D Altstiel, et al.
American Journal of Medical Genetics|April 9, 1996
Evidence of a locus for schizophrenia and related disorders on the short arm of chromosome 5 in a large pedigreeJ M Silverman, D A Greenberg, L D Altstiel, et al.
Journal of Neurochemistry|January 9, 2001
Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brainH F Dovey, V John, J P Anderson, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Alzheimer Disease and Associated Disorders|June 19, 2002
Barriers to Alzheimer disease drug discovery and development in the biotechnology industryL D Altstiel
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1991
Cytokines in Alzheimer's diseaseL D Altstiel, K Sperber
Journal of Virology|July 1, 1981
Structural changes in BHK cell plasma membrane caused by the binding of vesicular stomatitis virusL D Altstiel, F R Landsberger
Dementia (Basel, Switzerland)|January 1, 1995
Elevated alpha 1-antichymotrypsin serum levels in a subset of nondemented first-degree relatives of Alzheimer's disease patientsL D Altstiel, B Lawlor, R Mohs, et al.
The American Journal of Psychiatry|May 20, 1998
Association of elevated alpha 1-antichymotrypsin with cognitive impairment in a prospective study of the very oldS M Gabriel, D B Marin, P S Aisen, et al.
Genetic Epidemiology|January 1, 1996
Apolipoprotein E-epsilon 4 allele and familial risk in Alzheimer's diseaseG Li, J M Silverman, L D Altstiel, et al.
American Journal of Medical Genetics|April 9, 1996
Evidence of a locus for schizophrenia and related disorders on the short arm of chromosome 5 in a large pedigreeJ M Silverman, D A Greenberg, L D Altstiel, et al.
Journal of Neurochemistry|January 9, 2001
Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brainH F Dovey, V John, J P Anderson, et al.
Pageof 1